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The discovery of RNA silencing as a sequence-specific 
gene regulation mechanism in eukaryotes has been heralded 
as the most exciting breakthrough in current biology. The 
seminal work of Baulcombe and Hamilton in 1999 provided 
a key insight into the potential function of a tiny RNA spe-
cies of approximately 25 nucleotides (nt) in RNA silencing 
in plants [1]. Subsequently, Tuschl and colleagues [2,3] 
demonstrated that small RNAs of similar size mediated 
RNA interference (RNAi) in insect and mammalian cells. 
These discoveries uncovered a previously unrecognized 
small RNA world and led to a surge in interest in small 
RNA biology. Now small RNAs are well recognized as 
ubiquitous, versatile regulators of gene expression in plants, 
fungi and animals [4,5]. 
On the basis of their origins, biogenesis and mode of ac-
tion, small RNAs can be categorized into three major clas-
ses: small interfering RNAs (siRNAs), microRNAs (miR-
NAs) and Piwi-associated interfering RNAs (piRNAs). 
siRNA is about 21–24 nt in size and is processed from a 
perfect base-paired double stranded RNA (dsRNA) precur-
sor by RNase III-like enzymes termed Dicers [6]. miRNA is 
also a cleavage product of Dicer enzymes from an imperfect 
RNA hairpin formed through inter-molecular base-pairing 
and is mostly 21 nt long [7]. piRNA is generated in a Dicer-     
independent manner with longer size (from 24 to 32 nt) than 
miRNAs and siRNAs, and is highly enriched in animal 
germ line cells [8]. Genetic and biochemical studies in Ara-
bidopsis thaliana, Caenorhabditis elegans, Drosophila mel-
anogaster and other model organisms have provided frame-
works of small RNA-mediated regulation mechanisms. In 
brief, these small RNAs associate with a diverse of proteins 
from the Argonaute family and form the core RNA silenc-
ing processor called RNA-induced silencing complexes 
(RISCs). Small RNAs guide the RISCs to search for target 
RNAs by base pairing and cause degradation or translation 
inhibition of cognate mRNAs, or changes in chromatin 
structure [9].  
Plants are particularly rich in diversity of small RNAs. 
Thus far several different types of endogenous small RNAs 
have been identified in plants: trans-acting siRNAs (ta- 
siRNAs), natural antisense transcripts-derived siRNAs (nat- 
siRNAs), heterochromatic siRNAs (hc-siRNAs), long siR-
NAs (lsiRNAs) and miRNA [10]. These small RNAs par-
ticipate in virtually every aspect of plant life, such as de-
velopment timing [11,12], chromatin remodeling [13,14], 
genome protection [15] as well as responses to biotic and 
abiotic stresses [16–18].  
In plants, small RNAs can also be produced from invad-
ing exogenous nucleic acids such as viruses, and these vi-
rus-derived siRNAs target cognate RNAs for specific deg-
radation [19,20]. If a recombinant virus harboring a se-
quence fragment of a plant gene, the cognate endogenous 
mRNAs can be degraded upon virus infection [21]. This 
principle inspires scientists to develop a novel reverse ge-
netics tool known as virus-induced gene silencing (VIGS). 
VIGS represents a simple, fast and transformation-free ap-
proach for gene loss-of-function assay, and has been widely 
used for plant functional genomics, especially in species 
that are less amenable to traditional genetic manipulation 
[22–24]. On the other hand, the small RNA-mediated natu-
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ral antiviral response in plants can be reinforced by ex-
pressing a sequence of viral origin that potentiates the host 
RNA silencing defense mechanism [25]. This strategy, 
which is known as pathogen-derived resistance, has been 
very successfully utilized in molecular breeding program 
for viral disease resistance even long before our mechanistic 
understanding of RNA silencing [26,27]. One outstanding 
example is the control of Papaya ringspot virus in Hawaii 
by transgenic expression of viral coat protein gene in papa-
ya plants [28]. While Fire and Mello [29] made the break-
through discovery in 1998 that dsRNA is the trigger of 
RNA silencing, Waterhouse et al. [30] showed that trans-
genic expressing a dsRNA structure derived from a viral 
sequence effectively induced RNA silencing and conferred 
specific virus immunity. Since then, this approach has been 
well adopted for genetic engineering for crop resistance to 
infections of all major classes of plant viruses [31,32]. In an 
analogous process termed host-induced gene silencing 
(HIGS), transgenic expression of dsRNAs in plant triggers 
robust silencing of cognate mRNAs expressed by invading 
fungi [33,34], nematode [35,36], parasitic plant [36,37] and 
even chewing insects [38,39]. HIGS has emerged as a 
promising strategy to create transgenic germplasm for pest 
control [40]. In addition, small RNA-based technologies can 
be harnessed to modify crop agronomic trait to enhance 
stress tolerance and to increase yields [41,42]. Studies of 
viral counter-defense measure led to the discovery of viral 
suppressors of RNA silencing. These suppressors not only 
facilitate our better understanding of RNA silencing path-
way [43–45], but also serve to increase foreign protein pro-
duction in transgenic plants [46]. 
In animals, the biogenesis and function of miRNAs have 
been studied extensively. Animal miRNAs have more re-
laxed base-pairing requirements and thus regulate greater 
numbers of target mRNAs than their plant counterparts do. 
Another different aspect of animal miRNAs is that their 
targets are often subjected to translation repression instead 
of RISC-mediated destruction [47]. It is estimated that hu-
man genome gives rise to well over 800 mature miRNAs 
[48]. Each miRNA may regulate hundreds of genes and a 
majority of genes may be controlled by one or more miR-
NAs [7]. The normal miRNA activities are needed in proper 
regulation of many cellular processes ranging from cell dif-
ferentiation to apoptosis, whereas dysregulation of miRNA 
expression is associated with various disease conditions 
[49]. Therefore these miRNAs may serve as novel diagnos-
tic biomarkers [50] and therapeutic targets [51]. One such 
example is the development of a locked nucleic acid-based 
antisense oligonucleotide “Miravirsen” that specifically 
inhibits miR-122 [52], a liver specific miRNA that is re-
quired for Hepatitis C virus replication [53]. Report from 
the Phase IIa clinical trial showed that Miravirsen provided 
robust dose-dependent anti-viral activity that was main-
tained beyond the end of therapy [54], highlighting the 
therapeutic potential of miRNA-based medicine.  
Although the diversity and function of endogenous si- 
RNAs in human cells have not been fully delineated, it has 
been well established that the RNAi machinery can utilize 
exogenous siRNAs to shut off human gene expression [2]. 
This has led to the siRNA-based RNAi approach that now 
has been routinely used in both basic and applied studies 
[55]. Numerous genome-wide RNAi screenings with syn-
thetic siRNA molecules have begun to systemically identify 
important genes implicated in various cellular pathways 
[56]. An important practical consideration is that knocking 
down the abnormal expression of disease-causing genes by 
administrated siRNA drugs may offer clinical benefits. By 
2011, nearly 30 small RNA-based therapeutic agents had 
undergone clinical trials for treatment of various diseases, 
including cancers, physiological and metabolic disorders 
and viral infections [57,58]. The bench-to-bedside transla-
tion of small RNA biology can be anticipated in the near 
future.  
Since the discovery of RNA silencing, research on small 
RNAs is probably one of the most rapidly advancing fields 
in the contemporary biology. Numerous efforts have been 
made to uncover the repertoire and diversity of small RNAs 
in the past 15 years. This process is greatly expedited by the 
technical advances in high-throughput deep sequencing of 
small RNA, leading to an information explosion in the small 
RNAome [59]. The availability of newly annotated genome 
sequences also contribute to small RNA profiling through 
comparative genomics analyses [60,61]. With the ever-      
increasing small RNA species, a major challenging problem 
is to identify the targets of small RNAs and to annotate their 
functions. Genetic and biochemical dissection of RNA si-
lencing pathway in model organisms will continue to ex-
pand our appreciation for the small RNA-mediated regula-
tory mechanisms. Improvement of current computational 
algorithms will likely facilitate our understanding of more 
comprehensive miRNA targetome [62–64]. New advances 
in RNA-Seq technologies may enable the experimental 
examination of changes in target gene expression when 
miRNA level is deliberately altered [63,65]. Development 
of methods for real-time monitoring small RNA activities in 
vivo may provide new insights into their functions in normal 
physiology and disease [66–68]. Breakthroughs in small 
RNA delivery methodology could increase its efficacy and 
minimize side effect [69]. We can anticipate that advances 
in fundamental small RNA biology will make a big differ-
ence in agricultural biotechnology and biomedicine. 
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